rheumatology
Medicines

Is persistence the outcome measure we should be striving for in rheumatology?

Sponsored by Janssen-Cilag Pty Ltd

“Persistence is a relatively new word in the vocabulary of rheumatologists, but it could likely become a factor that helps clinicians decide which treatments to use, and when” explains Graeme Jones, Consultant Rheumatologist and Professor of Rheumatology and Epidemiology at the University of Tasmania. the limbic spoke with Professor Jones and Associate Professor Peter Wong, ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic